Therapeutic application of human type 2 innate lymphoid cells via induction of granzyme B-mediated tumor cell death
Zhenlong Li(City Of Hope National Medical Center), Jianhua Yu(City Of Hope National Medical Center)
Cited by 91
Related Papers
YTHDF2 orchestrates tumor-associated macrophage reprogramming and controls antitumor immunity through CD8+ T cells
|Nature Immunology|2023|217
An Oncolytic Virus Expressing IL15/IL15Rα Combined with Off-the-Shelf EGFR-CAR NK Cells Targets Glioblastoma
|Cancer Research|2021|210
Transcription Factor Foxo1 Is a Negative Regulator of Natural Killer Cell Maturation and Function
|Immunity|2015|184